Total group number (%) | BVO number (%) | TVO number (%) | PVO number (%) | Significance | |
---|---|---|---|---|---|
Medical treatment | 219 (100) | 105 (100) | 42 (100) | 72 (100) | NS |
Only medical treatment | 119 (54.3) | 70 (66.7) | 10 (23.8)7-150 | 39 (54.2) | p < 0.0001 |
Therapeutic failure | 27 (12.7) | 15 (14.3) | 10 (23.8) | 2 (2.8)7-150 | p < 0.005 |
Surgical treatment | 100 (45.6) | 35 (33.3) | 32 (76.2)7-150 | 33 (45.8) | p < 0.00001 |
Relapse† | 10 (4.8) | 3 (2.9) | 3 (7.3) | 4 (5.8) | NS |
Death | 7 (3.2) | 2 (1.9) | 3 (7.3) | 2 (2.8) | NS |
Severe funtional sequelae† | 67 (32.3) | 18 (18.1)7-150 | 17 (49.3) | 29 (41.2) | P < 0.0001 |
↵7-150 Significant difference with respect to the other groups. †Percentages calculated over 207 patients who completed the follow up. Abbreviations as in table 2.